SB
Shubham Bansal
About Shubham Bansal
Data last updated:
Shubham Bansal is a Director at Inventive Impex Private Limited (since 2020), Director at Vsk Pharma Private Limited (since 2019) and Director at Ethico Pharma Private Limited (since 2019), and holds 3 more current directorships. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹56.7 Lakh; the largest is Inventive Impex Private Limited at ₹48.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Inventive Impex Private Limited U51909DL2009PTC193882 | Director | 26 Oct 2020 | 2009 | ₹48.8 Lakh (FY 2025) | Active |
| Vsk Pharma Private Limited U24232DL2008PTC173981 | Director | 02 Aug 2019 | 2008 | ₹7.9 Lakh (FY 2024) | Active |
| Ethico Pharma Private Limited U24230DL2009PTC197422 | Director | 27 Jul 2019 | 2009 | ₹2,303 (FY 2025) | Active |
| Medipedia Pharmaceuticals Private Limited U46497DL2026PTC463052 | Director | 05 Feb 2026 | 2026 | Active | |
| Inventive Medicare (India) Llp AAK-9662 | Designated Partner | 01 Aug 2022 | 2017 | Active | |
| Fibrient Healthcare Llp ABB-1996 | Designated Partner | 29 May 2022 | 2022 | Active |
Board colleagues of Shubham Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anju Aggarwal | 08977651 | Inventive Impex Private Limited | Director |
| Dhruv Aggarwal | 10360751 | Inventive Impex Private Limited | Director |
| Kirti Gupta | 09585852 | Vsk Pharma Private Limited | Director |
| Gagan Bansal | 07214181 | Ethico Pharma Private Limited | Director |
| Satyam Bansal | 08743389 | Ethico Pharma Private Limited | Director |
| Sandeep Duggad | 11526341 | Medipedia Pharmaceuticals Private Limited | Director |
| Lalita Devi | 02422235 | Inventive Medicare (India) Llp | Designated Partner |
| Kirti Gupta | 10004092 | Fibrient Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shubham Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shubham Bansal
Shubham Bansal currently holds 6 directorships: Inventive Impex Private Limited (Director, since 26 Oct 2020, revenue ₹48.8 Lakh (FY 2025)); Vsk Pharma Private Limited (Director, since 02 Aug 2019, revenue ₹7.9 Lakh (FY 2024)); Ethico Pharma Private Limited (Director, since 27 Jul 2019, revenue ₹2,303 (FY 2025)); Medipedia Pharmaceuticals Private Limited (Director, since 05 Feb 2026); Inventive Medicare (India) Llp (Designated Partner, since 01 Aug 2022); and 1 more.
Shubham Bansal was first appointed on 27 Jul 2019 as Director at Ethico Pharma Private Limited. The most recent appointment on record is 05 Feb 2026 at Medipedia Pharmaceuticals Private Limited.
The 3 current companies of Shubham Bansal that report revenue have a combined latest revenue of ₹56.7 Lakh: Inventive Impex Private Limited ₹48.8 Lakh (FY 2025); Vsk Pharma Private Limited ₹7.9 Lakh (FY 2024); Ethico Pharma Private Limited ₹2,303 (FY 2025).
The current boards of Shubham Bansal's companies include Anju Aggarwal (Inventive Impex Private Limited), Dhruv Aggarwal (Inventive Impex Private Limited), Kirti Gupta (Vsk Pharma Private Limited), Gagan Bansal (Ethico Pharma Private Limited), Satyam Bansal (Ethico Pharma Private Limited), Sandeep Duggad (Medipedia Pharmaceuticals Private Limited), among others.